• English Version
  • 首页
  • 关于我们
    • 研发外包业务
    • 开发和生产外包业务
    • 企业荣誉
    • 出版刊物
  • 一站式医药研发和生产服务
  • 化药研发
    • 药物化学
    • 化合物库
    • 合成化学
    • 多肽化学
    • 基于片段筛选(FBS)
    • 计算机辅助药物设计
    • 分析服务
    • 结构生物学
  • 生物与药理药效学
    • 肿瘤学
    • 病理学核心实验室
    • 免疫学
    • 肿瘤免疫学
    • 神经科学
    • 细胞生物学
    • 体外药理药效
    • 代谢疾病和心血管疾病研发
    • 表观遗传学
  • 药代动力学与早期毒理
    • 药代动力学/早期毒理学部门
    • 生物标示物、临床前及和临床样品的生物分析
    • 大分子药代/生物分析服务
  • 生物药研发
    • 抗体研发
    • 蛋白质科学组
    • 生物制药分析表征服务
    • B细胞克隆服务
  • 生物药工艺开发与生产
    • 稳定细胞株开发
    • 工艺开发
    • 制剂研发
    • 无菌灌装和冻干
    • 成药性研究
    • 包材可提取物和析出物研究
    • 分析方法开发和放行检测
    • GMP生产
  • 化药工艺开发与生产
    • 工艺研发
    • 工艺安全
    • 处方前研究
    • 配方开发
    • ICH稳定性研究
    • CTD 报告的CMC部分的编写
    • 生产
  • 博客
  • 人才招聘
  • 新闻信息
  • 联系我们
  • 下载中心
sales@chempartner.com
English
上海睿智 上海睿智
  • 首页
  • 关于我们
    • 上海睿智
    • 研发外包业务
    • 开发和生产外包业务
    • 企业荣誉
    • 出版刊物
  • 研发服务
    • 化药研发
      • 合成化学
      • 化合物库
      • 药物化学
      • 多肽化学
      • 基于片段筛选(FBS)
      • 计算机辅助药物设计
      • 分析服务
      • 结构生物学
    • 生物与药理药效学
      • 肿瘤学
      • 病理学核心实验室
      • 免疫学
      • 肿瘤免疫学
      • 细胞生物学
      • 体外药理药效
      • 神经科学
      • 代谢疾病和心血管疾病研发
      • 表观遗传学
    • 药代动力学与早期毒理
      • 药代动力学/早期毒理学部门
      • 生物标示物、临床前及和临床样品的生物分析
      • 大分子药代/生物分析服务
    • 生物药研发
      • 抗体研发
      • 蛋白质科学组
      • 生物制药分析表征服务
      • B细胞克隆服务
    • 生物药工艺开发与生产
      • 稳定细胞株开发
      • 工艺开发
      • 制剂研发
      • 无菌灌装和冻干
      • 成药性研究
      • 包材可提取物和析出物研究
      • 分析方法开发和放行检测
      • GMP生产
    • 化药工艺开发与生产
      • 工艺研发
      • 工艺安全
      • 分析开发
      • 处方前研究
      • 配方开发
      • ICH稳定性研究
      • CTD 报告的CMC部分的编写
      • 生产
  • 博客
  • 人才招聘
  • 新闻信息
  • 联系我们
  • 下载中心

睿智化学被GHP评为“2017年最佳生命科学CRO”

Home 企业新闻睿智化学被GHP评为“2017年最佳生命科学CRO”

睿智化学被GHP评为“2017年最佳生命科学CRO”

2017年10月22日 企业新闻

上海睿智化学研究有限公司在《全球医疗健康与制药》(GHP:Global Health & Pharma)杂志举办的“2017年医疗健康与制药奖”评选中荣获?“最佳生命科学CRO”奖。GHP杂志拥有超过25万人的读者群, 该杂志设立的“2017年医疗健康和制药奖”,旨在表彰年度医疗健康和制药行业中表现最为突出的公司、部门和个人。睿智化学凭借其雄厚的科研实力、全面的解决方案以及快速的业务增长获此殊荣。GHP对睿智化学首席商务官Livia Legg女士进行了采访。

Best Life Science CRO 2017

ChemPartner is a leading research organization providing high-quality and cost-effective services for the biopharmaceutical industry. We invited Livia Legg, Chief Commercial Officer, to discuss the services the company offers and explore the services behind its success.

As a world-class organization with exceptional scientists and experienced leaders, ChemPartner understands what it takes to be the partner of choice for drug discovery and pharmaceutical and biotechnology companies look for service organizations that can provide intellectual input, along with technical expertise. ChemPartner stands out to be not only a global contract research and manufacturing organization (CRO/CMO), but also a true pharmaceutical alliance partner. ?Livia Legg, Chief Commercial Officer, discusses the firm’s specific focus.

“Since its inception in 2002, ChemPartner has evolved from a pure chemistry provider located in China to a global drug discovery and development service organization with laboratories and business operation in China, the US, Europe, and Japan. In addition to chemistry, our portfolio services include Biology, Biologics, Drug Metabolism Pharmacokinetic (DMPK), and Chemical Manufacturing and Control (CMC) for both small molecule and biologic therapeutics. Our growth and transformation are fueled by successfully operating a business model based on operational excellence, customer satisfaction, and value creation.”

Experience is a key factor in the success of ChemPartner. The company and its staff of experts are fully dedicated to helping clients to reach time-sensitive goals and to fulfill high expectations, something Livia explains.

“Over the past 15 years in business, ChemPartner has acquired deep institutional knowledge and experience as well as demonstrated a track record of success. Our leadership team has breadth and depth of knowledge in drug discovery gained through many years of pharmaceutical industry experience. Our scientists provide intellectual input to our clients and jointly solve complex scientific and technical problems.”

As with any major company, ChemPartner must offer something unique in order to attract business and clients. ChemPartner does this by working cohesively, both internally and with clients, and by boasting a high-quality team collaborating on a worldwide basis as Livia points out.

“ChemPartner is compromised of experienced, dedicated, and passionate individuals with a love for science and commitment to service. Our motto at ChemPartner is One Team, Our Success. This operational philosophy guides how we think and act, and is evident in the way we communicate, coordinate, and collaborate with our colleague and clients. Additionally, we balance the benefits of global reach with the need for local presence by operating laboratories and offices in major pharma/biotech hubs throughout the world. This enables us to develop face-to-face relationships, establish mutual understanding and trust, form productive and long-term partnerships, and develop cross-functional ChemPartner -client teams.”

With a dynamic force of synthetic and medicinal chemists, chempartner continues to be a leading chemistry service organization. The company has successfully designed and synthesized millions of molecules for hundreds of pharmaceutical and biotech companies worldwide. However, ChemPartner does not just focus on chemistry.

“Chemistry is a cornerstone business for ChemPartner, and we continue to invest in China and the US. Leveraging our expanded service portfolio, we couple chemistry together with our biology and DMPK capabilities to deliver a truly integrated solution for discovering chemical “hits” and transforming them into candidate drugs.

ChemPartner’s rapid growth in biologics mirrors the industry trend, and our biologics team has the expertise to discover, express, purify, and analyze monoclonal antibodies and recombinant proteins.

“As our clients’ programs progress to first-in-human studies, our CMO companies, China Gateway Pharmaceutical Development and China Gateway Biologics, seamlessly transfer projects from late preclinical into early stage clinical development, process development, and cGMP manufacturing services.”

Because the pharmaceutical research and development landscape is constantly evolving, ChemPartner must remain ahead of the curve. Livia explains that ChemPartner stays on the leading edge through continued advancements.

As science-driven and technology-based CRO, we are committed to providing innovative solutions to serve the rapidly changing needs of our clients. We build for the future by remaining on the forefront of science and technology. To this end, we listen to our clients, participate in the industry meetings, and consult our Scientific Advisory Board to identify emerging trends and ensure we remain current and competitive. Further, we attract talent with key expertise and develop future leaders through mentoring, training, and educational programs, including an international visiting scientist program.”

Lastly, with ChemPartner aiming to capitalize on its recent success, Livia confirms that the strong organization will continue to work hard and smart to provide high-quality services to their clients and sustain a successful future for the company.

“ChemPartner’s success is powered by the success of our clients. We will continue to align our goals, develop innovative solutions, and execute our clients to successfully bring new medicines to market.”

原文链接:Link to the article in the awards edition of the GHP magazine?(Page 16-17)

Tags: 2017Best Life ScienceCRO睿智化学
0
Share

You also might be interested in

睿智化学参展波士顿第12届蛋白质抗体工程峰会(PEGS)

睿智化学参展波士顿第12届蛋白质抗体工程峰会(PEGS)

5月 4, 2016

由CHI主办的第12[...]

尚华医药集团宣布进入中国资本市场的第二里程碑

6月 19, 2017

中国,上海(2017[...]

ChemPartner赞助肽治疗基金会(PTF)

10月 25, 2017

中国上海,2017年[...]

最新信息

公司更名为睿智医药,加速医药健康产业创新赋能

2020年9月23日

...

江苏睿智生物药商业化生产基地正式启用,量子生物创新药服务一体化战略再落一子

2020年9月11日

...

专访凯惠睿智项骏博士 | 打通研发生产全产业链,助推国内创新药上市步伐

2020年9月11日

 ...

“药燃”启东-2020生物医药产融互动论坛成功落幕

2020年9月11日

...

上海睿智宣布对生物药业务进行投资升级,以拓展各业务部门产能,进一步打通生物药研发、开发与生产的全面布局。

2020年6月11日

...

上海国家技术转移中心科创型企业家培育计划—锐意进取,寻求产业升级新机遇

2020年6月9日

...

标签云

2017 AACR Agreement Antibody Engineering art Best Life Science Blend ChemPartner CNAS Congratulates CPhI CPSA CRO Frontier Forum Labs layout PEGS PEGS CHINA product PTF Qidong Research Facility San Diego San Francisco Shanghai ShangPharma Tarveda World ADC 上海睿智 创新药 化学 基金会 多肽治疗 尚华 尚华集团 战略性联盟 波士顿 睿智化学 艾跃生物 蛋白质抗体 资产重组 赞助 重组 量子生物 量子高科

联系我们

logo如果您有任何问题需要咨询到我们,您可以在这里给我们快速留言。

发送信息
请联系我们,了解更多的一站式医药研发和生产服务。 给我们留言

Logo

上海睿智是一家世界领先的科研外包服务机构,为生物制药行业提供高质高效的医药研发服务。

更多了解

联系我们
  • 上海睿智化学研究有限公司
  • 上海市浦东新区张江高科技园区金科路2829号A栋1层、3层,邮编:201203
  • +86 21 5132 0088
  • sales@chempartner.com

© 2023 — Shanghai ChemPartner Co., Ltd. All Rights Reserved  沪ICP备17056048 关于我们  服务概览  人才招聘  联系我们  隐私策略  站点地图

  • 首页
  • Buy Highend
上一篇 下一篇